Laser-induced hypopigmentation can be treated with a combination of approaches including topical calcineurin inhibitors, targeted phototherapy, fractional laser resurfacing paired with prostaglandin analogs, and platelet-rich plasma injections. The good news is that most cases are not permanent: in one study of patients who developed hypopigmentation after laser skin resurfacing, the light patches faded on their own within a year in about 85% of cases. But when the color loss lingers or covers a visible area, active treatment can speed repigmentation considerably.
Why Lasers Sometimes Cause Light Patches
Melanocytes, the cells responsible for skin color, sit in the deepest layer of the epidermis. When a laser targets pigment or heats surrounding tissue aggressively enough, melanocytes can be damaged or destroyed along with the intended target. The physics involves extreme local heat: when melanin-containing structures called melanosomes absorb laser energy, they heat up fast enough to generate tiny vapor bubbles that expand and physically rupture nearby cells. If the melanosomes are densely packed, the peak temperatures climb higher and the mechanical damage is worse.
This explains why certain skin types are more vulnerable. People with darker skin have more melanin spread throughout the epidermis, which means the laser’s energy gets absorbed more broadly rather than staying confined to the intended target. That extra absorption raises the risk of collateral melanocyte injury. High energy settings, short wavelengths, pulse stacking, and tight treatment intervals all increase the danger.
Who Is Most at Risk
Darker skin tones (Fitzpatrick types IV through VI) face the highest risk because melanin acts as a competing absorber for the laser’s energy. Aggressive protocols on any skin type can cause hypopigmentation, but the combination of higher baseline melanin and strong laser parameters is the most common setup for trouble. Treatments for conditions like melasma, where repeated low-fluence laser “toning” sessions are popular, carry a particular risk of mottled hypopigmentation that can look confetti-like and be distressing to patients.
The type of laser matters too. Q-switched lasers used for tattoo removal and pigment disorders are well-documented culprits. The Q-switched 1064-nm Nd:YAG laser, for instance, is effective and generally safe, but hypopigmentation remains a recognized side effect that can cause significant anxiety.
The Natural Timeline of Recovery
Before diving into active treatments, it is worth understanding that laser-induced hypopigmentation often resolves spontaneously. A study of patients who underwent Er:YAG laser skin resurfacing found that hypopigmentation appeared in roughly 14% of them, typically about two months after the procedure. In 85% of those affected, the light patches faded within a year without targeted intervention. This means the first reasonable step after noticing post-laser hypopigmentation is watchful waiting for several months, especially if the affected area is small or easily concealed. Active treatment usually begins when the color change persists beyond six months to a year, or when the cosmetic impact is severe enough that the patient does not want to wait.
Topical Calcineurin Inhibitors
Topical calcineurin inhibitors like tacrolimus and pimecrolimus are a first-line topical option. These are prescription creams originally developed for eczema, but they have found a second life in treating hypopigmented conditions including vitiligo. Their value for laser-induced hypopigmentation comes from a two-part mechanism: they calm the immune activity that can keep melanocytes suppressed, and they directly stimulate melanocyte growth, migration, and melanin production. A case report documented successful treatment of laser-induced mottled hypopigmentation using a combined regimen of topical calcineurin inhibitors and fractional COâ‚‚ laser.
In practice, your dermatologist might prescribe tacrolimus ointment to apply to the light patches once or twice daily for several months. The treatment is generally well tolerated, though some people experience mild burning or stinging when they first start. Because these creams do not thin the skin the way corticosteroids can, they are safe for longer-term use on the face and other sensitive areas where hypopigmentation tends to be most noticeable.
Targeted Phototherapy
Ultraviolet light has been used to stimulate pigment production for decades, and two forms are particularly relevant here: narrowband UVB (NB-UVB) therapy and the 308-nm excimer laser.
NB-UVB delivers a specific band of ultraviolet light that is especially good at activating melanocytes. A case report of laser-induced hypopigmentation from a Q-switched Nd:YAG laser showed rapid and satisfactory repigmentation with NB-UVB targeted phototherapy. The advantage of NB-UVB is that it can treat broader areas efficiently and has a long track record in conditions like vitiligo.
The 308-nm excimer laser delivers the same wavelength as NB-UVB but in a focused beam, making it ideal for treating smaller, well-defined patches without exposing surrounding normal skin to UV. In a study of hypopigmented scars and striae, the excimer laser achieved a visual pigment correction of about 60 to 70% relative to surrounding normal skin after nine sessions. Colorimetric measurements showed even fuller correction, reaching roughly 100% of normal pigmentation at that point. The catch is that this improvement gradually faded over the following six months, suggesting that maintenance sessions or combination therapy may be needed for lasting results.
These phototherapy options work by nudging dormant or sluggish melanocytes back into action. For post-laser hypopigmentation specifically, targeted NB-UVB has the advantage of being a well-established clinical approach with minimal side effects when properly dosed.
Fractional Laser Resurfacing
It might seem counterintuitive to treat laser damage with more laser, but fractional laser resurfacing works on a different principle from the laser that caused the problem. Instead of blanketing an area with energy, fractional lasers create thousands of tiny microscopic columns of treatment surrounded by untouched skin. This triggers a wound-healing response that can coax melanocytes from the surrounding healthy tissue to migrate into the treated zones.
Both ablative fractional lasers (like fractional COâ‚‚) and nonablative fractional lasers (like the erbium-doped 1,550-nm device) have been studied. On their own, they produce modest improvement in pigmentation. The real gains come when fractional resurfacing is combined with topical agents that promote melanocyte activity, because the laser-created micro-channels allow those topicals to penetrate much deeper than they normally would.
Prostaglandin Analogs as Repigmentation Boosters
Prostaglandin analogs, particularly latanoprost and bimatoprost, were originally developed as eye drops for glaucoma. A well-known side effect of these medications is that they darken skin and stimulate pigment production, which researchers have turned into a therapeutic advantage for hypopigmented scars and post-laser color loss.
A systematic review of studies combining laser-assisted delivery with topical prostaglandin analogs found strong results: in both placebo-controlled and non-controlled trials, more than 75% of patients achieved at least 50% repigmentation or better. A retrospective study included in that review reported that every single patient achieved at least 75% repigmentation. The typical protocol involves performing fractional laser resurfacing and then immediately applying the prostaglandin analog solution to the treated skin, allowing the medication to seep into the micro-channels created by the laser.
A randomized controlled trial specifically evaluating latanoprost combined with fractional COâ‚‚ laser for hypopigmented burn scars confirmed that the combination produced significant repigmentation. The prostaglandin appears to stimulate melanocyte activity through pathways that complement the wound-healing response triggered by the laser itself.
Bimatoprost, a closely related prostaglandin, has also been used successfully. In one detailed case, a patient with facial hypopigmentation underwent microneedling sessions followed by fractional COâ‚‚ laser treatments, with bimatoprost solution applied after each session and also used at home twice daily. After three laser sessions spaced six weeks apart, the patient had sustained repigmentation at a 10-month follow-up. This approach of combining an in-office procedure with at-home topical application seems to yield the best outcomes.
Platelet-Rich Plasma
Platelet-rich plasma (PRP) is made by drawing a small amount of your blood, concentrating the platelets in a centrifuge, and injecting the resulting growth-factor-rich liquid into the affected skin. The rationale for using PRP in hypopigmentation is that the concentrated growth factors help prevent melanocyte death and stimulate the proliferation of surviving melanocytes. PRP activates signaling pathways that protect a key protein involved in melanocyte survival, ultimately encouraging these cells to multiply and produce pigment again.
PRP has been reported as effective for treating hypopigmentation in case reports, and a meta-analysis of randomized controlled trials found that combining PRP with fractional laser improved repigmentation in vitiligo patients compared with laser alone. While vitiligo and laser-induced hypopigmentation are not the same condition, they share a common problem: too few functional melanocytes in the affected area. PRP addresses this at a cellular level by creating a more favorable environment for melanocyte recovery.
The treatment typically requires multiple sessions spaced a few weeks apart. Some practitioners combine PRP injections with fractional laser resurfacing in the same visit, using the laser micro-channels to deliver PRP deeper into the skin rather than relying solely on injection. The evidence is still growing, but PRP is increasingly offered as part of combination protocols for stubborn post-laser hypopigmentation.
Microneedling as a Delivery Platform
Microneedling uses fine needles to puncture the top layer of skin, creating channels that improve the absorption of topical medications. For hypopigmentation, microneedling serves a dual purpose: the controlled micro-injuries themselves trigger a wound-healing cascade that can stimulate melanocyte activity, and the channels allow prostaglandin analogs, PRP, or calcineurin inhibitors to reach the deeper skin layers where melanocytes live.
Microneedling is less aggressive than fractional laser resurfacing, which can make it a better starting point for patients who are understandably wary of more laser treatment. The case described earlier using bimatoprost started with microneedling sessions before graduating to fractional COâ‚‚ laser, and the patient saw improvements at each stage. For milder cases, microneedling plus topical prostaglandin alone may be sufficient without adding a second laser procedure.
Low-Level Laser Therapy
Low-level laser therapy (LLLT), also called photobiomodulation, uses very low-energy light (typically red or near-infrared wavelengths) that does not heat or damage tissue. Unlike the high-energy lasers that caused the hypopigmentation in the first place, LLLT works by gently stimulating cellular activity. In pigmentary disorders, LLLT has been shown to increase pigmentation by promoting melanocyte proliferation and to reduce depigmentation by calming autoimmune activity that can target melanocytes. The evidence base for LLLT in laser-induced hypopigmentation specifically is thinner than for excimer laser or fractional resurfacing, but the extremely low risk profile makes it an appealing adjunct, particularly for patients who want to avoid anything that feels aggressive.
Cellular Grafting for Severe or Refractory Cases
When topical treatments and light-based therapies fail, surgical approaches become an option. Non-cultured epidermal cellular grafting is a technique developed for vitiligo that involves harvesting a thin sample of your own normal skin, separating the cells (including melanocytes), and transplanting them onto the depigmented area. The technique has been refined since its introduction in the early 1990s and can be applied to stable hypopigmented patches that have not responded to less invasive treatments.
This approach is usually reserved for cases where the hypopigmentation has been present for over a year and has not improved with other interventions. It requires a stable patch, meaning one that is not actively changing in size or shape. The procedure can achieve excellent color matching because the transplanted melanocytes come from your own body, but it is more involved than other options and typically performed by dermatologic surgeons with specialized training.
Combining Treatments for Better Results
The consistent theme across the research is that combination therapy outperforms any single approach. Fractional laser alone produces modest repigmentation. Add a prostaglandin analog, and the improvement jumps substantially. Layer in PRP or a calcineurin inhibitor, and outcomes improve further. A review of laser treatment for hypopigmented scars concluded that while fractional lasers alone offer modest benefit, enhanced repigmentation occurs when they are combined with prostaglandin analogs and other agents that promote melanin production.
A practical treatment ladder might look like this for someone with persistent post-laser hypopigmentation:
- Step one: Topical tacrolimus applied daily, with or without targeted NB-UVB phototherapy sessions, for three to six months.
- Step two: If improvement stalls, add fractional laser resurfacing with topical latanoprost or bimatoprost applied immediately after each session.
- Step three: Consider PRP injections alongside the fractional laser sessions for added melanocyte stimulation.
- Step four: For truly refractory cases, discuss melanocyte grafting with a specialist.
Your dermatologist will adjust this sequence based on the size and location of the hypopigmentation, your skin type, and how long the color loss has been present.
Prevention During Future Laser Treatments
If you have experienced laser-induced hypopigmentation once, your risk is higher for future laser procedures, and prevention becomes a serious consideration. Research on laser toning for melasma emphasizes that using gentler treatment settings (lower fluence and lower total cumulative energy), adjusting treatment intervals based on skin response, and closely monitoring for early signs of pigment loss can help avoid irreversible hypopigmentation. The moment a lighter spot appears, treatment should be paused rather than pushed forward.
For people with darker skin tones, the precautions are even more critical. Longer wavelengths, lower energy densities, longer pulse durations, and extended intervals between sessions all reduce the risk of melanocyte damage. Some practitioners perform test spots in inconspicuous areas before committing to a full treatment, which can reveal individual susceptibility before it becomes a cosmetic problem.
Cosmetic Camouflage While You Wait
Regardless of which active treatment you pursue, repigmentation takes time. Most protocols require multiple sessions over months, and even successful treatments show gradual rather than sudden improvement. During this period, cosmetic camouflage can make a meaningful difference in daily life. Specialized camouflage products are formulated to be waterproof, transfer-resistant, and color-matched to a wide range of skin tones. They differ from regular foundation in their opacity and longevity and can effectively mask hypopigmented patches on visible areas like the face, neck, and hands.
Self-tanning products containing dihydroxyacetone (DHA) offer another option. DHA reacts with proteins in the outer skin layer to produce a temporary brown color that can help even out tone. The effect lasts several days before fading, and the product can be reapplied as needed. Neither camouflage makeup nor self-tanners treat the underlying problem, but they can substantially reduce the psychological burden while you wait for melanocytes to recover. That emotional toll should not be dismissed: the visible nature of post-laser hypopigmentation, especially on the face, can cause real distress, and acknowledging that while pursuing treatment is part of good care.